BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 6414751)

  • 21. Plasma concentrations of isosorbide dinitrate and mononitrates after acute and chronic oral administration of isosorbide dinitrate in man.
    Bruyneel K; Rosseel MT; Bogaert MG
    Arzneimittelforschung; 1982; 32(7):769-73. PubMed ID: 6889879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
    Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
    Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isosorbide dinitrate disposition in the rat: metabolite pharmacokinetics and interactions.
    Morrison RA; Fung HL
    J Pharmacol Exp Ther; 1984 Oct; 231(1):124-30. PubMed ID: 6491969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
    Abrams J
    Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic extraction of isosorbide dinitrate in cardiac patients.
    Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Kasper W; Meinertz T; Fung HL
    Clin Pharmacol Ther; 1983 Dec; 34(6):724-31. PubMed ID: 6641086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrates in the elderly. Pharmacological considerations.
    Kelly JG; O'Malley K
    Drugs Aging; 1992; 2(1):14-9. PubMed ID: 1554970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates.
    Slack CJ; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1381-5. PubMed ID: 2516767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assay of glyceryl trinitrate, isosorbide dinitrate, and their metabolites in plasma by large-bore capillary column gas-liquid chromatography.
    Booth BP; Bennett BM; Brien JF; Elliott DA; Marks GS; McCans JL; Nakatsu K
    Biopharm Drug Dispos; 1990 Nov; 11(8):663-77. PubMed ID: 2125512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.
    Elkayam U; Aronow WS
    Drugs; 1982 Mar; 23(3):165-94. PubMed ID: 6804202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isosorbide 5-mononitrate pharmacokinetics.
    Chasseaud LF
    Cardiology; 1987; 74 Suppl 1():6-11. PubMed ID: 3300979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results.
    Steudel HC; Volkenandt M; Steudel AT
    Z Kardiol; 1983; 72 Suppl 3():24-8. PubMed ID: 6666228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
    Bogaert MG; Rosseel MT; Boelaert J; Daneels R
    Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the clinical and hemodynamic effects of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate in acute myocardial infarction].
    Lazebnik LB; Tereshchenko SN; Gendel'man AM
    Kardiologiia; 1991 Oct; 31(10):13-5. PubMed ID: 1753569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some pharmacological properties of organic nitrates.
    Osnes JB
    Scand J Clin Lab Invest Suppl; 1984; 173():19-25. PubMed ID: 6098958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of isosorbide mononitrate.
    Abshagen UW
    Am J Cardiol; 1992 Nov; 70(17):61G-66G. PubMed ID: 1449102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Historical aspects of nitrate therapy.
    Berlin R
    Drugs; 1987; 33 Suppl 4():1-4. PubMed ID: 3113909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
    Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
    Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
    Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of nitroglycerin and long-acting nitrates.
    Abrams J
    Am J Cardiol; 1985 Jul; 56(2):12A-18A. PubMed ID: 3925750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.
    Chasseaud LF; Down WH; Grundy RK
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):157-60. PubMed ID: 1233213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.